Halabi, S., Luo, B., Dzimitrowicz, H., Hwang, C., Wise-Draper, T. M., Labaki, C., … Warner, J. (2022). 501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19. In Annals of Oncology (Vol. 33, pp. S771–S772). Elsevier BV. https://doi.org/10.1016/j.annonc.2022.07.629

Halabi, S., B. Luo, H. Dzimitrowicz, C. Hwang, T. M. Wise-Draper, C. Labaki, R. R. McKay, et al. “501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19.” In Annals of Oncology, 33:S771–72. Elsevier BV, 2022. https://doi.org/10.1016/j.annonc.2022.07.629.

Halabi S, Luo B, Dzimitrowicz H, Hwang C, Wise-Draper TM, Labaki C, et al. 501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19. In: Annals of Oncology. Elsevier BV; 2022. p. S771–2.

Halabi, S., et al. “501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19.” Annals of Oncology, vol. 33, Elsevier BV, 2022, pp. S771–72. Crossref, doi:10.1016/j.annonc.2022.07.629.

Halabi S, Luo B, Dzimitrowicz H, Hwang C, Wise-Draper TM, Labaki C, McKay RR, Ruiz E, Rangel-Escareño C, Farmakiotis D, Griffiths EA, Jani CT, Accordino M, Friese C, Wulff-Burchfield E, Puc M, Yu P, Topaloglu U, Mishra S, Warner J. 501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19. Annals of Oncology. Elsevier BV; 2022. p. S771–S772.